Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
Clinical teams have access to a wealth of data, most of it structured and peer-reviewed, from which they're able to mine insights about how a given medicine performs in a defined patient population | Clinical teams have long used real world evidence to understand how a drug works. Now commercial teams can mine evidence from unstructured data to drive action.
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise

Written by Guy Amster, Senior Principal Machine Learning Engineer, Flatiron Health | The differentiator isn't algorithms; it's…

Drug commercialization depends on reaching the right physicians at the right moment. | Drug commercialization depends on reaching…

Market research shouldn’t lag behind decisions. With AI, organizations can transform it into a sensing engine, continuously…

Unlocking AI’s potential in biotech requires more than advanced models. Download this white paper to explore why trusted,…

Despite unprecedented access to data and AI, many life sciences organizations still struggle to make confident commercial…

How can timely, precise lab data improve decision-making across the medicine lifecycle? Download this whitepaper to explore how…